Oramed Pharmaceuticals Statistics
Total Valuation
ORMP has a market cap or net worth of $107.07 million. The enterprise value is -$26.76 million.
Important Dates
The last earnings date was Thursday, November 13, 2025, after market close.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ORMP has 39.80 million shares outstanding. The number of shares has increased by 3.29% in one year.
| Current Share Class | 39.80M |
| Shares Outstanding | 39.80M |
| Shares Change (YoY) | +3.29% |
| Shares Change (QoQ) | +0.39% |
| Owned by Insiders (%) | 13.27% |
| Owned by Institutions (%) | 10.76% |
| Float | 31.35M |
Valuation Ratios
The trailing PE ratio is 2.62.
| PE Ratio | 2.62 |
| Forward PE | n/a |
| PS Ratio | 55.61 |
| Forward PS | n/a |
| PB Ratio | 0.54 |
| P/TBV Ratio | 0.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 22.24, with a Debt / Equity ratio of 0.00.
| Current Ratio | 22.24 |
| Quick Ratio | 22.08 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 24.48% and return on invested capital (ROIC) is -4.53%.
| Return on Equity (ROE) | 24.48% |
| Return on Assets (ROA) | -4.22% |
| Return on Invested Capital (ROIC) | -4.53% |
| Return on Capital Employed (ROCE) | -6.07% |
| Revenue Per Employee | $500,000 |
| Profits Per Employee | $10.96M |
| Employee Count | 4 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ORMP has paid $11.94 million in taxes.
| Income Tax | 11.94M |
| Effective Tax Rate | 21.41% |
Stock Price Statistics
The stock price has increased by +6.75% in the last 52 weeks. The beta is 1.17, so ORMP's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | +6.75% |
| 50-Day Moving Average | 2.46 |
| 200-Day Moving Average | 2.28 |
| Relative Strength Index (RSI) | 58.84 |
| Average Volume (20 Days) | 240,567 |
Short Selling Information
The latest short interest is 245,076, so 0.62% of the outstanding shares have been sold short.
| Short Interest | 245,076 |
| Short Previous Month | 241,868 |
| Short % of Shares Out | 0.62% |
| Short % of Float | 0.78% |
| Short Ratio (days to cover) | 1.71 |
Income Statement
In the last 12 months, ORMP had revenue of $2.00 million and earned $43.85 million in profits. Earnings per share was $1.03.
| Revenue | 2.00M |
| Gross Profit | 13,000 |
| Operating Income | -13.01M |
| Pretax Income | 55.74M |
| Net Income | 43.85M |
| EBITDA | -12.89M |
| EBIT | -13.01M |
| Earnings Per Share (EPS) | $1.03 |
Full Income StatementBalance Sheet
The company has $134.69 million in cash and $860,000 in debt, giving a net cash position of $133.83 million or $3.36 per share.
| Cash & Cash Equivalents | 134.69M |
| Total Debt | 860,000 |
| Net Cash | 133.83M |
| Net Cash Per Share | $3.36 |
| Equity (Book Value) | 202.33M |
| Book Value Per Share | 4.98 |
| Working Capital | 130.00M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.59 million and capital expenditures -$18,000, giving a free cash flow of -$10.61 million.
| Operating Cash Flow | -10.59M |
| Capital Expenditures | -18,000 |
| Free Cash Flow | -10.61M |
| FCF Per Share | -$0.27 |
Full Cash Flow StatementMargins
Gross margin is 0.65%, with operating and profit margins of -650.55% and 2,192.60%.
| Gross Margin | 0.65% |
| Operating Margin | -650.55% |
| Pretax Margin | 2,787.20% |
| Profit Margin | 2,192.60% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |